Brown Wealth Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$687K Buy
240,136
+4,000
+2% +$12.3K 0.15% 68
2026
Q2
$718K Hold
236,136
– – 0.16% 69
2026
Q1
$727K Sell
236,136
-22,537
-9% -$95.7K 0.19% 66
2025
Q4
$934K Buy
258,673
+25,000
+11% +$109K 0.25% 57
2025
Q3
$881K Buy
233,673
+2,590
+1% +$10K 0.25% 58
2025
Q2
$894K Buy
231,083
+131,059
+131% +$709K 0.28% 53
2025
Q1
$500K Buy
100,024
+50,024
+100% +$317K 0.17% 59
2024
Q4
$360K Sell
50,000
-248
-0.5% -$1.9K 0.13% 62
2024
Q3
$309K Buy
50,248
+248
+0.5% +$1.68K 0.11% 65
2024
Q2
$332K Hold
50,000
– – 0.13% 65
2024
Q1
$509K Sell
50,000
-25,000
-33% -$254K 0.21% 54
2023
Q4
$844K Buy
+75,000
New +$313K 0.37% 41

Other funds holding ALT

Brown Wealth Management's ALT Position: Q3 2026 in Review

Brown Wealth Management increased its Altimmune (ALT) stake by 1.7% in Q3 2026, buying an estimated $12.3K and bringing the position to 240,136 shares worth $687K. The position accounts for 0.15% of the portfolio, ranked #68.

Brown Wealth Management first reported a position in ALT in Q4 2023 and has held it in 12 quarters since. The position peaked at $934K in Q4 2025. 23 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Brown Wealth Management held 240,136 shares of Altimmune worth $687K as of Q3 2026.
  • Brown Wealth Management bought 4,000 Altimmune shares in Q3 2026, an estimated $12.3K.
  • Altimmune made up 0.15% of Brown Wealth Management's portfolio in Q3 2026, its #68 holding.
  • Brown Wealth Management first reported a position in Altimmune in Q4 2023 and has held it in 12 quarters since.
  • Brown Wealth Management's Altimmune position peaked at $934K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Brown Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.